See All Slides - tctmd.com

Slides

Presentation TCT 2017

Welcome and Comments From the New CEO of CRF: Goals and Vision

Presenter: Spencer B. King III, Patrick W. Serruys, Juan F. Granada

October 30, 2017

Presentation TCT 2017

Will Robotic Technology Ever Facilitate Tele-stenting Over Long Geographic Distances?

Presenter: Bernard De Bruyne, Evelyn S. Regar, Ryan D. Madder

October 30, 2017

Presentation TCT 2017

Case #4: TAVR for Pure Native Aortic Regurgitation - A Horrifying Ride

Presenter: Jun-Jack Cheng, Wasan Udayachalerm, Wei-Hsian Yin

October 30, 2017

Presentation TCT 2017

Is PE Really a Team Sport? Benefits and Disadvantages of PERT

Presenter: Michael R. Jaff, Robert A. Lookstein, Kenneth Rosenfield

October 30, 2017

Presentation TCT 2017

TAVR should be reserved for intermediate and higher-risk tricuspid valve aortic stenosis!

Presenter: A. Pieter Kappetein

October 30, 2017

Presentation TCT 2017

Safety and Feasibility of a Novel, Second Generation Robotic-assisted System for Percutaneous Coronary Intervention: First-in-Human Report

Presenter: Bernard De Bruyne, Evelyn S. Regar, Christopher Smitson

October 30, 2017

Presentation TCT 2017

Case #3: Rescue From Left Main Occlusion With Severe Aortic Stenosis

Presenter: Jun-Jack Cheng, Wasan Udayachalerm, Tetsuya Kaneko

October 30, 2017

Presentation TCT 2017

Predicting The Future: Will the Ongoing DES 3-Month DAPT Studies With Synergy and Xience Change How We Treat High Risk Bleeding Patients?

Presenter: C. Michael Gibson, Stephan Windecker

October 30, 2017

Presentation TCT 2017

The CADence Device in the Physiologic Evaluation of Acoustic Coronary Turbulence

Presenter: Bernard De Bruyne, Evelyn S. Regar, Joseph Thomas

October 30, 2017

Presentation TCT 2017

Were ready to treat bicuspid valve and lower-risk tricuspid valve aortic stenosis!

Presenter: Susheel K. Kodali

October 30, 2017

Advertisement

Slides

Welcome and Comments From the New CEO of CRF: Goals and Vision

Will Robotic Technology Ever Facilitate Tele-stenting Over Long Geographic Distances?

Case #4: TAVR for Pure Native Aortic Regurgitation - A Horrifying Ride

Is PE Really a Team Sport? Benefits and Disadvantages of PERT

TAVR should be reserved for intermediate and higher-risk tricuspid valve aortic stenosis!

Safety and Feasibility of a Novel, Second Generation Robotic-assisted System for Percutaneous Coronary Intervention: First-in-Human Report

Case #3: Rescue From Left Main Occlusion With Severe Aortic Stenosis

Predicting The Future: Will the Ongoing DES 3-Month DAPT Studies With Synergy and Xience Change How We Treat High Risk Bleeding Patients?

The CADence Device in the Physiologic Evaluation of Acoustic Coronary Turbulence

Were ready to treat bicuspid valve and lower-risk tricuspid valve aortic stenosis!

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content